Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Nasdaq Biotechnology Ishares ETF (NQ: IBB)
119.59 USD  -0.44 (-0.37%)
Streaming Delayed Price  /  Updated: 12:39 PM EST, Dec 9, 2019  /  Add to My Watchlist      
View: Quote News
Fund Overview
Nasdaq Biotechnology Ishares ETF
Sector
Exchange Traded NQ
Net Assets 10.40B
Inception Date
Related Funds
Quote
Price 119.59
Volume 944,202
Last Trade Dec 09, 12:39pm
Change (%)
-0.44 (-0.37%)
Prev. Close 120.03
YTD %
+22.66%
Dividend Yield 0.26%
Performance
YTD
+22.09 (22.66%)
1 Month
+9.23 (8.36%)
3 Month
+17.76 (17.44%)
6 Month
+16.38 (15.87%)
1 Year
+15.77 (15.19%)
Chart
Charting
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Investors Are Moving Back Into Resurgent Biotech ETFs
After stumbling through much of 2019, biotechnology ETFs are finding their grooves in the fourth quarter. Since the start of the current quarter, the iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB) is... Read More
from ETF Trends
The Economic Modern Family - How Are They Looking?
After a brief visit to lower prices, almost everyone in the sector-representative ETFs gained in price this past week. We give honorable mention to the Russell 2000 IWM. Not only did IWM show bullish... Read More
from Blogs - TalkMarkets
Top News
More News
The Week Ahead In Biotech: ASH Presentations Pick Up Steam, Correvio Awaits Adcom Ruling
Biotech stocks went back and forth but managed to end the week with a gain. As usual, some stocks swung wildly in reaction to catalysts, ... Read More
from Benzinga
IBB Is Positioned For Outperformance
iShares Nasdaq Biotechnology ETF is benefitting from reduced regulatory risk in the middle term. The ETF is still trading below its highs of 2015, so it has a lot of ground to recover going forward. Read More
from Blogs - TalkMarkets
The Daily Biotech Pulse: Cassava Gains On Alzheimer's Presentation, Bristol-Myers Hikes Dividend
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting ... Read More
from Benzinga
Emerging Markets - How They Are Shaping Up for 2020
While the US market, particularly the S&P 500 and NASDAQ have made new all-time highs recently in 2019, one can see the disconnect of the underperformance in emerging markets. Read More
from Blogs - TalkMarkets
Thursday's ETF Movers: CQQQ, IBB
In trading on Thursday, the Invesco China Technology ETF (CQQQ) is outperforming other ETFs, up about 1.3% on the day. Components of that ETF showing particular strength include shares of Autohome... Read More
from ETF Channel
The Daily Biotech Pulse: Aurinia Rips Higher On Positive Readout, Sesen Bio On Track For Vicinium BLA Submission
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... Read More
from Benzinga
The Market Bears Fade To Black
On November 4th, SMH gapped higher and since it was a new all-time high, that made the pattern a clean breakaway gap. Until yesterday, that gap held. Read More
from Blogs - TalkMarkets
The Daily Biotech Pulse: Roche's Tecentriq Snags FDA Nod For Lung Cancer, Rapt Out-Licenses Cancer Drug
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... Read More
from Benzinga
Was That The Market Selloff?
Bears won the dog fight from the bulls and the agnostics today. However, was this the dip to buy or the start of a way more major selloff? Read More
from Blogs - TalkMarkets
Pitfalls Of Biotechnology Investing
How capital distorts the availability of biotechnology companies. Read More
from Blogs - TalkMarkets
The Gene Therapy Names Moving On The Audentes Buyout Deal
Gene therapy company Audentes Therapeutics Inc (NASDAQ: BOLD) announced a deal late Monday to be acquired by Japanese pharma company ... Read More
from Benzinga
PreMarket Prep Recap: Red On The Screen And Looking For More
With a sea of red engulfing the markets Tuesday morning, there was plenty to discuss on thePreMarket Prep Show. When Red Is Not ... Read More
from Benzinga
The Daily Biotech Pulse: Astellas To Buy Audentes For $3B, Applied Genetics Chief Medical Officer Quits, Axsome Aces Midstage Trial
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that ... Read More
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.